Research map: Immunogenetic–metabolic profiles in clinically healthy siblings of patients with type 1 diabetes

Back to the article

Papers in this map

  1. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children · Anette G. Ziegler · 2013 · 1310 citations · Cited by this paper
  2. Prolactin, Estrogen, HbA1c and Interleukin-12 in Iraqi Smokers Single Females · 2025 · Related
  3. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children · Anette‐Gabriele Ziegler · 2011 · 82 citations · Cited by this paper
  4. Changes in bone tissue energy metabolism in diabetes mellitus and aging as a cause of increased skeletal fragility · 2026 · Related
  5. Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening · Ezio E. Bonifacio · 2025 · 28 citations · Cited by this paper
  6. Sarcopenia in postmenopausal patients with type 1 diabetes mellitus: characteristics of functional, laboratory, and instrumental indicators · 2026 · Related
  7. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes · Emily K. Sims · 2025 · 23 citations · Cited by this paper
  8. The role of trace elements in the pathogenesis of ocular surface diseases in type 2 diabetes mellitus: current concepts and clinical perspectives · 2026 · Related
  9. Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores · Mugdha V. Joglekar · 2024 · 20 citations · Cited by this paper
  10. Different weight loss strategies and their impact on fat and muscle tissue · 2026 · Related
  11. Risk for progression to type 1 diabetes in first-degree relatives under 50 years of age · Inés Urrutia · 2024 · 19 citations · Cited by this paper
  12. Prevalence of insulin resistance based on the estimated rate of glucose utilization among adult patients with type 1 diabetes and its role in predicting diabetic complications · 2025 · Related
  13. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children · Falastin Salami · 2022 · 18 citations · Cited by this paper
  14. Finerenone: features of action, current evidence base and examples of clinical application · 2026 · Related
  15. The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum · Carmella Evans‐Molina · 2025 · 17 citations · Cited by this paper
  16. Clinical and epidemiological characteristics of diabetes mellitus in children of the Republic of Sakha (Yakutia) · 2026 · Related
  17. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis · Lu You · 2024 · 14 citations · Cited by this paper
  18. Characteristics of type 1 diabetic patients with psychoorganic syndrome · 2026 · Related
  19. Precision Diagnostics: Using Islet Autoantibodies to Characterize Heterogeneity in Type 1 Diabetes · Jamie Lynn Felton · 2023 · 9 citations · Cited by this paper
  20. Impact of weight loss on GLP-1, glucagon and oxyntomodulin secretion in patients with obesity and type 2 diabetes · 2025 · Related
  21. Metabolic Phenotype of Stage 1 and Stage 2 Type 1 Diabetes Using Modeling of β Cell Function · Alfonso Galderisi · 2025 · 8 citations · Cited by this paper
  22. Islet autoantibodies and residual beta-cell function in children with type 1 diabetes depending on age of manifestation · Elizaveta Romanenkova · 2023 · 6 citations · Cited by this paper
  23. Rising Hemoglobin A1c in the Non-Diabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests · Kendra Vehik · 2022 · 1 citation · Cited by this paper
  24. Untitled · Cited by this paper

Source: OpenAlex (CC0)